The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
In Silico Models for Designing and Discovering Novel Anticancer Peptides
Open accessAbstract
Use of therapeutic peptides in cancer therapy has been receiving considerable attention in the recent years. Present study describes the development of computational models for predicting and discovering novel anticancer peptides. Preliminary analysis revealed that Cys, Gly, Ile, Lys, and Trp are dominated at various positions in anticancer peptides. Support vector machine models were developed using amino acid composition and binary profiles as input features on main dataset that contains experimentally validated anticancer peptides and random peptides derived from SwissProt database. In addition, models were developed on alternate dataset that contains antimicrobial peptides instead of random peptides. Binary profiles-based model achieved maximum accuracy 91.44% with MCC 0.83. We have developed a webserver, which would be helpful in: (i) predicting minimum mutations required for improving anticancer potency; (ii) virtual screening of peptides for discovering novel anticancer peptides, and (iii) scanning natural proteins for identification of anticancer peptides (http://crdd.osdd.net/raghava/anticp/).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Making Large-Scale Support Vector Machine Learning Practical
Joachims, T. (1998) · Advances in Kernel Methods · doi:10.7551/mitpress/1130.003.0015 · Cited by 1,613
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
CAMP: a useful resource for research on antimicrobial peptides.
Thomas, S., Karnik, S., Barai, R. S., Jayaraman, V. K., & Idicula-Thomas, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1021 · Cited by 462
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Mader, J. S., & Hoskin, D. W. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.933 · Cited by 430
Secondary structure of cell-penetrating peptides controls membrane interaction and insertion
Eiríksdóttir, E., Konate, K., Langel, Ü., Divita, G., & Deshayes, S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.03.005 · Cited by 323
Huang, Y.-B., Wang, X.-F., Wang, H.-Y., Liu, Y., & Chen, Y. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0811 · Cited by 224
DADP: the database of anuran defense peptides
Novković, M., Simunić, J., Bojović, V., Tossi, A., & Juretić, D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts141 · Cited by 218
Khalili, P., Arakelian, A., Chen, G., Plunkett, M. L., Beck, I., Parry, G. C., Doñate, F., Shaw, D. E., Mazar, A. P., & Rabbani, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0100 · Cited by 203
Membrane fluidity characteristics of human lung cancer
Sok, M., Šentjurc, M., & Schara, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00044-0 · Cited by 163
Antibacterial peptides and proteins with multiple cellular targets
Otvos, L. J. (2005) · Journal of Peptide Science · doi:10.1002/psc.698 · Cited by 162
Prediction of Cell Penetrating Peptides by Support Vector Machines
Sanders, W. S., Johnston, C. I., Bridges, S. M., Burgess, S. C., & Willeford, K. O. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002101 · Cited by 153
Hariharan, S., Gustafson, D. L., Holden, S. N., McConkey, D. J., Davis, D. W., Morrow, M., Basche, M., Gore, L., Zang, C., O’Bryant, C. L., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm140 · Cited by 130
Computational approach for designing tumor homing peptides
Sharma, A. B., Kapoor, P., Gautam, A., Chaudhary, K., Kumar, R., Chauhan, J. S., Tyagi, A. K., & Raghava, G. P. S. (2013) · Scientific Reports · doi:10.1038/srep01607 · Cited by 86
Self-citationGregorc, V., de Braud, F., Pas, T. M. D., Scalamogna, R., Citterio, G., Milani, A., Boselli, S., Catania, C., Donadoni, G., Rossoni, G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1376 · Cited by 56
Kozłowska, K., Nowak, J., Kwiatkowski, B., & Cichorek, M. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80074-8 · Cited by 40
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Likewise, Tyagi et al. 2013 developed an SVM-based platform for identifying new anti-cancer peptides [115].”
Wei, L., Zhou, C., Chen, H., Song, J., & Su, R. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty451 · Cited by 439
iACP: a sequence-based tool for identifying anticancer peptides
Chen, W., Ding, H., Feng, P., Lin, H., & Chou, K.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.7815 · Cited by 433
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Chiangjong, W., Chutipongtanate, S., & Hongeng, S. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5099 · Cited by 388
Metadata
- Authors
- Tyagi, A., Kapoor, P., Kumar, R., Chaudhary, K., Gautam, A., & Raghava, G. P. S.
- Venue
- Scientific Reports
- Published
- 2013-10-18
- Volume
- 3
- Issue
- 1
- Pages
- 2984-2984
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2118911320
- Cited by
- 320
- References
- 21
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.